Literature DB >> 32686090

Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease.

Shan Li1,2, Ying Liu1,2, Yueqin He1,2, Weiwei Rong1,2, Mingchao Zhang1, Limin Li1,2, Zhihong Liu1, Ke Zen1,2.   

Abstract

Infiltration of activated T cells into renal tissue plays an essential role in inflammatory nephropathy. However, the mechanism enabling the renal recruitment and activation of T cells remains elusive. Here we report that inflammatory cytokine-promoted antigen presentation by podocytes is a key for recruiting and activating specific T cells. Our results showed that diabetes-associated inflammatory cytokines IFNγ and IL-17 all upregulated expression of MHC-I, MHC-II, CD80 and CD86 on the podocyte surface. Both IFNγ and IL-17 stimulated the uptake and processing of ovalbumin (OVA) by mouse podocytes, resulting in presentation of OVA antigen peptide on the cell surface. OVA antigen presentation by podocytes was also validated using human podocytes. Furthermore, OVA antigen-presenting mouse podocytes were able to activate OT-I mouse T cell proliferation and inflammatory cytokine secretion, which in turn caused podocyte injury and apoptosis. Finally, OT-I mice subjected to direct renal injection of OVA plus IFNγ/IL-17 but not OVA alone exhibited OVA antigen presentation by podocytes and developed nephropathy in 4 weeks. In conclusion, antigen presentation by podocytes under inflammatory conditions plays an important role in activating T cell immune responses and facilitating immune-mediated glomerular disease development.
© 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  T cell; antigen presentation; cytokine; inflammatory renal disease; podocyte

Mesh:

Year:  2020        PMID: 32686090     DOI: 10.1002/path.5508

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

1.  B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway.

Authors:  Jiemei Li; Jing Niu; Wenjian Min; Jun Ai; Xu Lin; Jinhua Miao; Shan Zhou; Ye Liang; Shuangqin Chen; Qian Ren; Kunyu Shen; Qinyu Wu; Xiaolong Li; Weiwei Shen; Fan Fan Hou; Youhua Liu; Peng Yang; Lili Zhou
Journal:  Cell Death Differ       Date:  2022-06-16       Impact factor: 15.828

2.  Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Authors:  Liang Li; Wei Tang; Yan Zhang; Meng Jia; Limei Wang; Quanxin Li; Qingsheng Han; Xiuping Peng; Yusheng Xie; Jichao Wu; Ziying Wang; Junhui Zhen; Xiaojie Wang; Min Liu; Yu Sun; Chun Zhang; Fan Yi
Journal:  Mol Ther       Date:  2022-05-05       Impact factor: 12.910

Review 3.  Role of the adaptive immune system in diabetic kidney disease.

Authors:  Lingyun Kong; Sofianos Andrikopoulos; Richard J MacIsaac; Laura K Mackay; David J Nikolic-Paterson; Niloufar Torkamani; Neda Zafari; Evelyn C S Marin; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2021-12-21       Impact factor: 4.232

Review 4.  New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.

Authors:  Da-Wei Lin; Cheng-Chih Chang; Yung-Chien Hsu; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.